AP-303

N/A

Report date: 2025/06/09 14:36:08
NME

Base Information

Drug NameAP-303
Drug Alias NameAP-303AP303
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPeroxisome proliferator-activated receptor α agonistsPeroxisome proliferator-activated receptor γ agonists
TargetsPeroxisome proliferator-activated receptor αPeroxisome proliferator-activated receptor γ
Therapy Area/IndicationsRenal Insufficiency, ChronicDiabetic Nephropathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanghai Alebund Pharmaceuticals Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesAlebund Pharmaceutical (Shanghai) Co LtdShanghai Alebund Pharmaceuticals Ltd
Inactive CompaniesN/A
Active IndicationsRenal Insufficiency, ChronicDiabetic Nephropathies
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A